← Back to headlines
Zevra Therapeutics Stock Jumps 19% After Strong Q4 Earnings
Zevra Therapeutics saw its stock price surge by 19% following the announcement of its fourth-quarter earnings, which significantly surpassed consensus estimates.
10 Mar, 13:03 — 10 Mar, 13:03
Sources
Showing 1 of 1 sources
